Tripodi A, de Groot PG, Pengo V (IRCCS Cà Granda Ospedale Maggiore Policlinico
Foundation and Università degli Studi di Milano, Milan, Italy; Utrecht University Medical …

See also Galli M. The antiphospholipid triangle. This issue, pp 234–6. Summary
Background: The characteristics and the clinical course of antiphospholipid syndrome (APS) …

The antiphospholipid syndrome (APS) was fully recognized as a clinical entity in the early
1980s. Still, more than 30 years later, the epidemiology of APS is not well described, and …

Antiphospholipid antibodies (aPLs) are associated with arterial and venous thrombosis,
recurrent pregnancy loss and thrombocytopenia. Although aPLs have not yet been …

Venous or arterial thrombosis or pregnancy morbidity in the presence of circulating
antiphospholipid antibodies (aPL) define the antiphospholipid syndrome (APS). In terms of …

Background: The antiphospholipid syndrome (APS) is an important cause of acquired
thromboembolic complications and pregnancy morbidity. Its diagnosis is based on clinical …

Antiphospholipid syndrome (APS) is a clinical condition that has not been well defined yet.
Although the clinical component is well established, the laboratory part is a mood issue …

Antiphospholipid syndrome (APS) is an autoantibody-mediated acquired thrombophilia. It is
characterized by the presence of antiphospholipid antibodies (APL) that are directed against …

The antiphospholipid syndrome (APS) is an autoimmune condition characterized by
vascular thromboses and/or pregnancy morbidity, and its diagnosis currently requires …

The antiphospholipid syndrome (APS) is an autoimmune disorder characterized by the
occurrence of venous and arterial thromboses, often multiple, and obstetric-related adverse …